Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Refractory Patient-Derived Multiple Myeloma Cells, Growing in a Novel Humanized Mouse MM Model

被引：4
|
作者：
Noort, Willy A. [1 ]
Groen, Richard W. J. [1 ]
Raymakers, Reinier [1 ]
Aalders, Linda [1 ]
Hofhuis, Frans M. [1 ]
Van Kessel, Berris [1 ]
Van Velzen, Jeroen F. [1 ]
de Bruijn, Joost [2 ]
Yuan, Huipin [3 ]
van Bueren, Jeroen Lammerts [4 ]
Bloem, Andries C. [1 ]
Parren, Paul W. H. I. [4 ]
Lokhorst, Henk [1 ]
Mutis, Tuna [1 ]
Martens, Anton C. M. [1 ]
机构：
[1] UMC Utrecht, Utrecht, Netherlands
[2] Xpand Biotechnol, Bilthoven, Netherlands
[3] Xpand Biotechnol BV, Bilthoven, Netherlands
[4] Genmab BV, Utrecht, Netherlands
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.940.940
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
940
引用
收藏
页数：2
相关论文
共 41 条
  • [31] Y MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial
    Raab, Marc S.
    Engelhardt, Monika
    Blank, Antje
    Goldschmidt, Hartmut
    Agis, Hermine
    Blau, Igor W.
    Einsele, Hermann
    Ferstl, Barbara
    Schub, Natalie
    Roellig, Christoph
    Weisel, Katja
    Winderlich, Mark
    Griese, Janine
    Haertle, Stefan
    Weirather, Johannes
    Jarutat, Tiantom
    Peschel, Christian
    Chatterjee, Manik
    LANCET HAEMATOLOGY, 2020, 7 (05): : E381 - E394
  • [32] Targeting CS1, a newly identified human multiple myeloma antigen, by a novel humanized monoclonal antibody HuLuc63, blocks myeloma cell adhesion in the bone marrow microenvironment and induces potent cytotoxicity against myeloma cells even resistant to conventional and novel therapies
    Tai, Y. T.
    Song, W.
    Li, X. F.
    Burger, P.
    Lee, A.
    Leiba, M.
    Podar, K.
    Schlossman, R.
    Rice, A.
    van Abbema, A.
    Richardson, P.
    Munshi, N. C.
    DePinho, R. A.
    Afar, D.
    Anderson, K. C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 148 - 148
  • [33] Novel human monoclonal antibody against CD47 induces cell death in lymphoid malignant cells in vitro and in vivo:: Potential novel therapeutic agent for B-CLL.
    Shimizu, T
    Miyakawa, Y
    Fukushima, N
    Kikuchi, Y
    Iijima, S
    Kinoshita, Y
    Azuma, Y
    Ohizumi, I
    Okabe, H
    Ikeda, Y
    Kizaki, M
    BLOOD, 2004, 104 (11) : 688A - 688A
  • [34] A Novel Class of Bifunctional Immunotherapeutic That Exploit a Universal Antibody Binding Terminus (uABT) to Recruit Endogenous Antibodies to Cells Expressing CD38 Demonstrates Anti-Multiple Myeloma Activity in Vitro and Ex Vivo against Patient Tumor Cells
    Rossi, Ann Marie
    Bunin, Anna
    Iben, Lawrence
    Welsch, Matthew
    Berbasova, Tanya
    Riillo, Caterina
    Rossi, Marco
    Ohuchi, Masaki
    Alvarez, Enrique
    Kawakami, Naoko
    Nagasawa, Takayuki
    Tassone, Pierfrancesco
    Spiegel, David
    Rastelli, Luca
    BLOOD, 2019, 134
  • [35] A Phase I/II Study of BHQ880, a Novel Osteoblat Activating, Anti-DKK1 Human Monoclonal Antibody, in Relapsed and Refractory Multiple Myeloma (MM) Patients Treated with Zoledronic Acid (Zol) and Anti-Myeloma Therapy (MM Tx)
    Padmanabhan, Swaminathan
    Beck, Joseph Thaddeus
    Kelly, Kevin R.
    Munshi, Nikhil C.
    Dzik-Jurasz, Andy
    Gangolli, Esha
    Ettenberg, Seth
    Miner, Kelly
    Bilic, Sanela
    Whyte, Winston
    Mehdi, Fazal
    Chiang, Lu-May
    Rae, Patricia Liz
    Spencer, Andrew
    Shah, Jatin
    Anderson, Kenneth C.
    Giles, Francis J.
    Stewart, A. Keith
    BLOOD, 2009, 114 (22) : 312 - 313
  • [36] UMG1, a novel humanized monoclonal antibody against a glysosylated-CD43-related epitope, induces antibody-dependent cellular cytotoxicity (ADCC) on human T-cell acute lymphoblastic leukemia cells
    Botta, Cirino
    Cantafio, Maria E. Gallo
    Buracchi, Chiara
    Siciliano, Maria A.
    Cuce, Maria
    Riillo, Caterina
    Tuccillo, Franca M.
    Caracciolo, Daniele
    Altomare, Emanuela
    Arbitrio, Mariamena
    Di Martino, Maria T.
    Rossi, Marco
    Biondi, Andrea
    Gaipa, Giuseppe
    Tagliaferri, Pierosandro
    Tassone, Pierfrancesco
    CANCER RESEARCH, 2018, 78 (13)
  • [37] A novel recombinant bispecific single-chain antibody, bscWue-1 × CD3, induces T-cell-mediated cytotoxicity towards human multiple myeloma cells
    D Hönemann
    P Kufer
    M M Rimpler
    M Chatterjee
    S Friedl
    F Riecher
    K Bommert
    B Dörken
    R C Bargou
    Leukemia, 2004, 18 : 636 - 644
  • [38] A novel recombinant bispecific single-chain antibody, bscWue-1 x CD3, induces T-cell-mediated cytotoxicity towards human multiple myeloma cells
    Hönemann, D
    Kufer, P
    Rimpler, MM
    Chatterjee, M
    Friedl, S
    Riecher, F
    Bommert, K
    Dörken, B
    Bargou, RC
    LEUKEMIA, 2004, 18 (03) : 636 - 644
  • [39] A first-in-class ex vivo combination between cytokine-induced memory like (CIML) NK cells and a CD38 targeting antibody recruiting molecule (ARM) as a novel approach to target NK cells without cellular engineering for the treatment of multiple myeloma.
    Rastelli, Luca
    Mohsin, Maqbool
    Rossi, Ann Marie
    Sotomayor, Enrique Alvarez
    Iben, Lawrence
    Vaill, Ada
    Welsch, Matthew
    Romee, Rizwan
    Bunin, Anna
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Co-operativity between antibody-dependent cellular cytotoxicity (ADCC) and immunotoxin-mediated killing of human T-ALL cells in a SCID mouse model: Simultaneous delivery of saporin via CD7 and ADCC via CD38 is no better than the simultaneous delivery of each against only CD7.
    Flavell, David J.
    Flavell, Sopsamorn U.
    BLOOD, 2006, 108 (11) : 208B - 208B
12345